Navigation Links
Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Date:8/19/2007

convertible security - - - (12,215)

Investment and other income 482 294 797 417

Change in fair value of

derivative instruments (2,401) (56) 1,123 (7,620)

Interest expense (643) (573) (1,267) (1,140)

Total other (expense)

and income (2,562) (335) 653 (20,558)

Net (loss) income $(12,104) $(3,757) $(15,991) $(30,593)

Net (loss) income per

share, basic $(0.43) $(0.14) $(0.57) $(1.23)

Net (loss) income per

share, diluted $(0.43) $(0.14) $(0.60) $(1.23)

Weighted average shares

outstanding, basic 28,313,056 25,952,342 28,305,810 24,815,680

Weighted average shares

outstanding, diluted 28,313,056 25,952,342 28,403,507 24,815,680

EMISPHERE TECHNOLOGIES, INC.

Condensed Balance Sheets (Unaudited)

As of June 30, 2007 and December 31, 2006

(in thousands)

June 30, December 31,

2007 2006

Assets:

Cash, cash equivalents, restricted cash and

investments $8,939 $21,533

Accounts receivable 487 216

Prepaid expenses and other current assets 893 1,082

Total current assets 10,319 22,831

Equipment and leasehold improvements, net 2,247 2,652

Purchased technology, net 1,675 1,794

Other assets 798 815

Total A
'/>"/>

SOURCE Emisphere Technologies, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... ROCKY HILL, Conn. , July 29, 2014 ... 28, 2014, Mike Swinford will be the company,s ... after a highly successful 22-year career at GE where he ... $200 million in annual revenue to over $5 billion. His ... Healthcare Global Services. "I am thrilled to ...
(Date:7/29/2014)... 29, 2014 McGraw-Hill Education Professional, a leading ... technical, and medical communities, has announced the launch of ... application of the world-renowned medical education platform. ... App , available for download onto all iOS and ... to gain access to valuable AccessMedicine diagnostic ...
(Date:7/29/2014)... 2014  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... second quarter 2014 financial results after the Nasdaq market ... host a live conference call and webcast to discuss ... morning, August 7, 2014 at 8:00 a.m. Eastern Time ... the live conference call by dialing 866-952-1907 (US) or ...
Breaking Medicine Technology:Numotion Names Mike Swinford CEO 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results 2
(Date:7/29/2014)... 29, 2014 The One Minute Herpes Cure ... Freeman, an herbal medicine specialist. Alison Freeman wanted to show ... , People interested in finding out more about this ... download it, as it is currently available in online format. ... natural remedies and herbal medicine tips that can help them ...
(Date:7/29/2014)... July 29, 2014 The Natural Multiple ... the inside story to Gary M. Levin’s cure program. ... cure method for this serious disorder. Levin says that ... conditions that can be found in patients. , ... surgeon. For many years, Levin has worked with patients ...
(Date:7/29/2014)... DailyGossip.org reveals in its Stop Sciatica in 8 ... of naturally overcoming sciatica, in less than 7 days. ... sufferers that the cure is simple to achieve, when ... method is described as very fast, as it promises ... minutes per day treatment plan. , Read more ...
(Date:7/29/2014)... Parker Waichman LLP, a national law ... by defective drugs and medical devices, reports that a ... Canada who allege that they were never warned about ... low testosterone injection Delatestryl (Court File No. 3704CP/14). The ... Ontario Superior Court of Justice. , “Testosterone lawsuits have ...
(Date:7/29/2014)... Denver, Colorado (PRWEB) July 29, 2014 Daily ... is a powerful and holistic system that will teach users ... been tried by thousands of people, from all over the ... of the symptoms of this disorder in as quickly as ... will be gone faster than imagined. , The Fibroids ...
Breaking Medicine News(10 mins):Health News:One Minute to Herpes Cure Review Reveals Simplest Herpes Treatment 2Health News:Natural Multiple Sclerosis Treatment Review Reveals the Inside Story to Gary M. Levin’s Cure Program 2Health News:Stop Sciatica in 8 Minutes Review Reveals the Way to Cure Sciatica Easily 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 3Health News:Amanda Leto’s Fibroids Miracle Review Reveals Clinically Proven Uterine Fibroids Cure System 2
... Aeras and the China National Biotech Group (CNBG) today ... organizations to pursue opportunities to jointly develop tuberculosis (TB) vaccines ... The partnership is intended to leverage both organizations, capabilities ... a major public health priority in China, where there are ...
... Serena Gordon HealthDay Reporter , MONDAY, July 25 (HealthDay ... worry to add to their list: Kids younger than 10 years ... on their own. New research found that while children ... the street solo -- they do stop and look both ways ...
... specific genes shuts down the mass production of antibodies launched ... by scientists at The University of Texas MD Anderson Cancer ... "Regulatory T cells prevent unwanted or exaggerated immune system ... been unclear," said paper senior author Chen Dong, Ph.D., professor ...
... ALBUQUERQUE, N.M. Americans are used to drinking from ... water utilities might be vulnerable to terrorist attacks or ... an open-source software developed by Sandia National Laboratories ... public water systems can be protected through enhanced detection ...
... , MONDAY, July 25 (HealthDay News) -- As ... school this fall, the American Lung Association urged parents to ... and help ease their transition back to the classroom. ... back-to-school necessities, it is even more essential for parents of ...
... of oncologists in the Program in Women,s Oncology at Women ... guide to the human papilloma virus (HPV) so physicians can ... women with the virus. Dx/Rx: Human Papilloma Virus was ... oncology at Women & Infants and associate professor of obstetrics ...
Cached Medicine News:Health News:Aeras and China National Biotech Group sign memorandum of understanding for TB vaccine R&D 2Health News:Kids With ADHD Less Adept at Crossing the Street: Study 2Health News:Kids With ADHD Less Adept at Crossing the Street: Study 3Health News:Specialized regulatory T cell stifles antibody production centers 2Health News:Specialized regulatory T cell stifles antibody production centers 3Health News:Sandia's CANARY software protects water utilities from terrorist attacks and contaminants 2Health News:Sandia's CANARY software protects water utilities from terrorist attacks and contaminants 3Health News:Preparation Key When Kids With Asthma Go Back to School 2Health News:Oncologists publish HPV manual for physicians 2
... The product is intended for ... spine following anterior fusion. The device ... addition, load sharing is enhanced through ... thickness. Anterior cervical single level interbody ...
... the newest addition to the ... plates. Ant-Cer addresses the unique ... the cervical spine. It enables ... to fit patients' unique needs. ...
... plate system is a family of plates ... provides for consistent, reliable fixation of plate ... or backout. This innovative design eliminates the ... implant your screws and the swivel ring ...
Investigational use spacer with Cantilever Transforminal Lumbar Interbody Fusion and instrumentation. For Investigational use only. 7 mm height....
Medicine Products: